Deferoxamine mesylate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68083-172
  • Package NDC 68083-172-01
  • Application number ANDA207384
  • SPL ID d14a31c5-4e8d-4e3e-b38f-d73ffddfb629
  • SPL set ID 598fba68-f46e-4b6e-894c-63c2940b2063
  • UNII V9TKO7EO6K
  • RxCUI 1731345
  • RxCUI 1731350

What the source publishes

Labeler
Gland Pharma Limited
Active ingredients
Deferoxamine mesylate
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68083-172_d14a31c5-4e8d-4e3e-b38f-d73ffddfb629
{
  "name": "Deferoxamine mesylate",
  "splId": "d14a31c5-4e8d-4e3e-b38f-d73ffddfb629",
  "labels": [
    {
      "setId": "598fba68-f46e-4b6e-894c-63c2940b2063",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=598fba68-f46e-4b6e-894c-63c2940b2063",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=598fba68-f46e-4b6e-894c-63c2940b2063"
    }
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS",
    "SUBCUTANEOUS"
  ],
  "labeler": "Gland Pharma Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-172-01)",
      "package_ndc": "68083-172-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171009"
    }
  ],
  "productId": "68083-172_d14a31c5-4e8d-4e3e-b38f-d73ffddfb629",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "68083-172",
  "deaSchedule": null,
  "genericName": "Deferoxamine mesylate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DEFEROXAMINE MESYLATE",
      "strength": "500 mg/1"
    }
  ],
  "applicationNumber": "ANDA207384",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20171009",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "V9TKO7EO6K"
    ],
    "rxcui": [
      "1731345",
      "1731350"
    ],
    "spl_set_id": [
      "598fba68-f46e-4b6e-894c-63c2940b2063"
    ],
    "manufacturer_name": [
      "Gland Pharma Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68083-172_d14a31c5-4e8d-4e3e-b38f-d73ffddfb629"